APGE
Apogee Therapeutics Inc.
Company Overview
| Mkt Cap | $2.18B | Price | $56.59 |
| Volume | 624.22K | Change | +0.98% |
| P/E Ratio | -12.0 | Open | $55.75 |
| Revenue | -- | Prev Close | $56.04 |
| Net Income | $-182.1M | 52W Range | $26.20 - $63.50 |
| Div Yield | N/A | Target | $94.30 |
| Overall | 75 | Value | 60 |
| Quality | -- | Technical | 91 |
No chart data available
Stock Overview
Updated DailyApogee Therapeutics Inc. (APGE) is a leading diversified company in the business industry, currently trading at $56.59 with a market capitalization of $2.18 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows APGE with a volume of 624K shares. The stock opened down 0.52% from yesterday's close of $56.04. Current analyst estimates project earnings of $-4.19 per share for this year, with next year targeting $-4.46.
APGE demonstrates very strong technical momentum based on technical analysis. The company trades on the NSD exchange.
Key investment considerations for APGE include strong overall investment metrics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 66.6%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 03:52 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | APGE | $56.59 | +1.0% | 624.22K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Apogee Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW